MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Gender-dependent behavioral and biochemical differences in the A53T genetic mouse model of Parkinson’s disease

G. Costa, M.J. Sisalli, L. Contu, A. Scorziello, M. Morelli (Cagliari, Italy)

Meeting: 2016 International Congress

Abstract Number: 1732

Keywords: Alpha-synuclein, Basal ganglia, Inflammation, Striatonigral degeneration

Session Information

Date: Thursday, June 23, 2016

Session Title: Other

Session Time: 12:00pm-1:30pm

Location: Exhibit Hall located in Hall B, Level 2

Objective: The main aim of the present study was to investigate whether behavioral and biochemical differences may occur between male and female old (12-month-old) transgenic A53T+/- and wild-type mice.

Background: Pathological hallmarks of Parkinson’s disease (PD) are loss of dopamine (DA) neurons with neuroinflammatory processes in the pars compacta of the substantia nigra (SNc) and in caudate-putamen (CPu), and missense mutations (e.g. A53T) in the α-synuclein gene. DA neuron degeneration leads to motor impairment, however PD also features a wide spectrum of autonomic manifestations including constipation, and displays a gender specificity since male are more affected than female.

Methods: Motor performance and coordination were evaluated by means of beam walking test. Time to traverse the beam, number of steps and errors per steps were recorded for each mouse. Stool frequency was evaluated by means of the one hours stool collection test, where dry weight and water content were determined from fecal pellets obtained during a 1 hour collection period. Immunohistochemical analysis of tyrosine hydroxylase (TH), as marker of DA neuron degeneration, glial fibrillary acidic protein (GFAP), as a marker of astroglia, and ionized calcium binding adaptor molecule-1 (Iba-1), as a marker of microglia, were evaluated in the SNc and CPu. Behavioral and biochemical experiments were carried out in both A53T+/- and wild-type male and female mice.

Results: A53T+/- male mice spent a significant longer time to traverse the beam, as compared with wild-type male and A53T+/- female mice. Moreover, the weight of the dry stool of A53T+/- male mice and the water content was lower, as compared with wild-type male mice and A53T+/- female mice. A significant increase of both GFAP- and Iba-1-positive cells was observed in the SNc and CPu of A53T+/- male mice, as compared with wild-type male and A53T+/- female mice. Moreover, A53T+/- male mice exhibited a significant loss of TH-positive neurons in the SNc, as compared with wild-type male and A53T+/- female mice.

Conclusions: Results showed that A53T+/- male mice may be more susceptible than female to the motor, autonomic and biochemical deficits that characterize PD.

To cite this abstract in AMA style:

G. Costa, M.J. Sisalli, L. Contu, A. Scorziello, M. Morelli. Gender-dependent behavioral and biochemical differences in the A53T genetic mouse model of Parkinson’s disease [abstract]. Mov Disord. 2016; 31 (suppl 2). https://www.mdsabstracts.org/abstract/gender-dependent-behavioral-and-biochemical-differences-in-the-a53t-genetic-mouse-model-of-parkinsons-disease/. Accessed May 14, 2025.
  • Tweet
  • Email
  • Print

« Back to 2016 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/gender-dependent-behavioral-and-biochemical-differences-in-the-a53t-genetic-mouse-model-of-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley